Assessment of angiogenesis in breast carcinoma: An important factor in prognosis?

Human Pathology

Volumn 26, Issue 11, 1995, Pages 1196-1200

  Goulding, H ^a   Nik Abdul Rashid, N F ^a   Robertson, J F ^a   Bell, J A ^a   Elston, C W ^a   Blamey, R W ^a   Ellis, I O ^a  

^a NOTTINGHAM CITY HOSPITAL   (United Kingdom)

Author keywords

angiogenesis; breast cancer; immunohistochemistry; prognosis

Indexed keywords

CD34 ANTIGEN; ESTROGEN RECEPTOR; MONOCLONAL ANTIBODY;

ANGIOGENESIS; ARTICLE; BREAST CARCINOMA; CANCER RECURRENCE; CLINICAL PROTOCOL; FEMALE; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LYMPH NODE; MAJOR CLINICAL STUDY; METASTASIS; PROGNOSIS; TISSUE SECTION; TUMOR VASCULARIZATION;

ANTIBODIES, MONOCLONAL; ANTIGENS, CD34; BREAST NEOPLASMS; ENDOTHELIUM, VASCULAR; FEMALE; HUMAN; IMAGE PROCESSING, COMPUTER-ASSISTED; IMMUNOHISTOCHEMISTRY; LYMPH NODES; NEOVASCULARIZATION, PATHOLOGIC; PROGNOSIS; VON WILLEBRAND FACTOR;

EID: 0028808919     PISSN: 00468177     EISSN: None     Source Type: Journal    
DOI: 10.1016/0046-8177(95)90193-0     Document Type: Article

References (42)

1. The relative significance of prognostic factors in breast cancer
2. Pathological prognostic factors in breast cancer 1: The value of histological grade in breast cancer: Experience from a large study with long-term follow up
3. Pathological prognostic factors in breast cancer 2: Histological type: Relationship with survival in a large study with long-term follow up
4. Pathological factors in breast cancer 3: Vascular invasion: Relationship with recurrence and survival in a large study with long-term follow up
5. Prognostic significance of oestrogen and progestogen receptor activities in breast cancer
6. Estrogen receptors and responses to chemotherapy and hormonal therapy in advanced breast cancer
7. Tumour angiogenesis: Therapeutic implications
8. What is the evidence that tumours are angiogenesis dependent?
9. Tumour angiogenesis correlates with metastasis in invasive prostatic carcinoma
10. Relation of neovascularisation to metastasis of non-small-cell lung cancer
11. Tumour angiogenesis and metastasis: Correlation in invasive breast carcinoma
12. Tumour angiogenesis: A new significant and independent prognostic indicator in early stage breast carcinoma
13. Tumour angiogenesis is an independent prognostic indicator in primary breast carcinoma
14. Angiogenesis in breast cancer: Regulation, prognostic aspects and implications for novel treatment strategies
15. Microvessel quantitation and prognosis in invasive breast carcinoma
16. Is the relationship between angiogenesis and metastasis in breast cancer real?
17. Microvessel density and local recurrence in patients with early stage breast cancer treated by wide excision alone (WEA)
18. Evaluation of tumour angiogenesis as a prognostic marker in breast cancer
19. Assessment of tumour vascularity as a prognostic factor in lymph node negative invasive breast cancer
20. Endothelial markers in malignant vascular tumours of the liver: Superiority of QB-END/10 over von Willebrand factor and Ulex europaeus agglutinin-1
21. Breast carcinoma: Comparative study of tumour vasculature using two endothelial cell markers
22. JC70: A new monoclonal antibody that detects vascular endothelium associated antigen on routinely processed tissue sections
23. Expression of the CD34 gene in vascular endothelial cells
24. Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer
25. The use of avdin-biotin-peroxidase complex (ABC) in diagnostic and research pathology
26. Calculation of survival rates by life table and other methods
27. Statistical aspects of the analysis of data from retrospective studies of disease
28. Quantitative relationships of intravascular tumour cells, tumour vessels and pulmonary metastasis following tumour implantation
29. The significance of hematogenous tumor cell clumps in the metastatic process
30. Pathogenesis of tumour stroma generation: A critical role for leaky blood vessels and fibrin deposition
31. Synthetic analogues of fumagilin that inhibit angiogenesis and suppress tumour growth
32. Angiogenesis inhibitor TNP-470 (AGM-1470) potently inhibits the tumour growth of hormone-independent human breast and prostate carcinoma cell lines
33. Prognostic significance of image morphometric microvessel enumeration in breast carcinoma
34. The prognostic significance of tumour vascularity in intermediate thickness (0.76-4.0 mm thick) skin melanoma
35. Vascular surface area as a prognostic indicator in invasive breast carcinoma
36. Angiogenesis induced by “normal” human breast tissue: A probable marker for precancer
37. Angiogenesis as a marker of preneoplastic lesions of the human breast
38. Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
39. Angiogenic factors
40. Tumour interactions with the vasculature: Angiogenesis and tumour metastasis